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This study was performed to detect and characterise the possible occurrence of natural and inducible
lectins in human serum by hemagglutination method, wherein, the serum was treated using exogenous
elicitors, namely, proteases and detergents.
Natural and inducible lectins were detected and characterised in human serum. Untreated serum
agglutinated buffalo and rabbit RBC, while serum treated with pronase, trypsin, a-chymotrypsin or SDS
for the very ﬁrst time, agglutinated hen/hen and sheep RBC within 15min in a dosimetric manner. Cross
adsorption test revealed that both trypsin and a-chymotrypsin-treated serum showed similar RBC
adsorption pattern. The lectin activity in untreated, pronase-treated serum was cation independent and
moderately sensitive/insensitive to calcium chelator EDTA, whereas, trypsin-treated serum was cation
dependent as well as EDTA sensitive (sheep RBC), cation independent and EDTA insensitive (hen RBC).
Hemagglutination of untreated serum was inhibited by certain glycosides and di-, oligo-saccharides,
whereas, activity in pronase-treated serum was inhibited by hexosamines. By contrast, hemagglutina-
tion of trypsin-treated serum showed speciﬁcity for acetylated mannosamine as well as sialic acid for
sheep RBC and certain glycoproteins for hen RBC.
Thus, we have detected inducible lectins with distinct ligand binding speciﬁcity, upon treatment of
human serum with proteases, namely, pronase and trypsin. Nevertheless, lectin activity was found in
untreated human serum too with different ligand speciﬁcity.
& 2012 Elsevier B.V. Open access under CC BY-NC-ND license.1. Introduction
Lectins are conventionally deﬁned as proteins/glycoproteins of
non-immune origin with an unique ability to speciﬁcally and
reversibly bind to carbohydrate structures present on cell sur-
faces, extracellular matrices, or secreted glycoproteins [1,2]. They
are ubiquitously distributed in microbes [3], plants [4] as well as
animals and humans [5–7]. In humans, about 49 distinct types of
lectins including selectins and galectins were reported to occur in
various cells, tissues, organs and in blood plasma/serum [8–14].
Six naturally occurring lectins have been detected in human
blood, that includes, C-reactive protein (CRP), serum amyloid
protein (SAP), H-ﬁcolin, mannan-binding lectin (MBL), tetranectin
and L-ﬁcolin. However, none of these humoral lectins were
detectable in crude serum by hemagglutination.
Isolated CRP, SAP and H-ﬁcolin could agglutinate, respectively,
pneumococcal capsular polysaccharide-coated sheep RBC [15],
complement-coated sheep RBC [16] and bacterial lipopolysac-
charide-coated human RBC [17]. Only Hamazaki [18] reportedan).
Y-NC-ND license.that isolated SAP can agglutinate horse and rat RBC. These
humoral lectins, with an exception of H-ﬁcolin [17] required
Ca2þ to bind various appropriate ligands. Indeed, few conﬂicting
reports indicate the divalent cation independent activity of CRP
[19,20], tetranectin [21] and L-ﬁcolin [22,23]. These lectins bind
to diverse simple to complex ligands, but predominantly,
N-acetylgalactosamine, N-acetylglucosamine, phosphoryl choline,
heparin, mannan and plasminogen can be considered to be the
best ligands for H-ﬁcolin, L-ﬁcolin, CRP, SAP, MBL and tetranectin,
respectively [17,22,24–28]. All these lectins could activate com-
plement system as well as mediate opsonophagocytosis by
macrophages and/or neutrophils. H-ﬁcolin could interact directly
with pathogenic bacteria and effectively abrogate their growth.
Apart from this lectin-mediated immune responses, the treatment
of various biochemical constituents with endogenous or exogen-
ous agents, result in generation of new immunologically relevant
molecules which could possibly augment the existing capacity of
host immune responsiveness.
Generation of potent antimicrobial activity from lactoferrin,
casein, albumin, egg white lysozyme and ovalbumin [29–33] has
been reported upon treatment with exogenous proteases.
Furthermore, lectin activity could be generated from egg white
lysozyme after chemical treatment [34]. Immunological functions
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models. Investigations as reported above are not observed in
human serum till date and thus we have explored the possibility
for generation of immunologically reactive molecules. Further-
more, it is also that these lectins generated by proteases (speci-
ﬁcally microbial protease) may have immunological functions,
because there are loads of microbes in our body that can produce
proteases into our system.
Representatives of proteases from different classes (serine,
aspartic, cysteine and non-speciﬁc) and detergents (anionic and
cationic), were chosen randomly for our initial analysis. Besides, it
is also clear from previous reports that some of these proteases as
well as SDS are known to elicit certain activity in various lower
animals and lectins obtained from induction of human serum
have not been reported till date. Hence, in the present study, we
detected and characterised generation of lectins in human serum
for the very ﬁrst time upon treatment with exogenous proteases
and detergents. Pure natural lectins were not tested, but, the
hemagglutinating activity and characteristics of untreated serum
was also extensively investigated for the ﬁrst time in order to
compare with the treated serum.2. Materials and methods
2.1. Materials
Trypsin, pronase, pepsin, phenylmethylsulphonyl ﬂuoride (PMSF),
amino acids as well as their derivatives, glycoproteins such as bovine
sub-maxillary mucin, asialo-BSM, fetuin, asialo-fetuin, thyroglobulin,
mucin, ovalbumin and phosphoryl choline were purchased from
Sigma chemical (Co., St Louis, USA). Papain and a-chymotrypsin
were obtained from SRL and Himedia, Mumbai, India, respectively.
Carbohydrates (mono-, di-, oligo- and polysaccharides) were pro-
cured from BDH, Fluka, Serva, Merck, Himedia and Sigma. All other
chemicals and reagents used in this study were of the highest
analytical grade purchased from local agencies.
2.2. Tris-buffered saline (TBS)
Eight different types of tris-buffered saline (TBS) containing
0.02% sodium azide were prepared as listed below and stored at
10 1C. The osmolalities were determined using Cryoscopic Osm-
ometer (Osmomat 030, Gonotec, Germany).
TBS-I (50mM Tris, 50mM NaCl, 50mM CaCl2, pH 7.5,
300mOsm), TBS-II (50mM Tris, 110mMNaCl, pH 7.5, 300mOsm),
TBS-III (50mM Tris, 115mM NaCl, 10mM CaCl2, pH 7.5,
300mOsm), TBS-IV (50mM Tris, 97mM NaCl, 25mM EDTA, pH
7.5, 300mOsm), TBS-V (50mM Tris, 25mM NaCl, 10mM CaCl2,
pH 7.5, 135mOsm), TBS-VI (50mM Tris, 90mM NaCl, 10mM
MgCl2, pH 7.5, 300mOsm), TBS-VII (50mM Tris, 95mM NaCl,
10mM SrCl2, pH 7.5, 300mOsm) and TBS-VIII (50mM Tris,
110mM NaCl, 1mM MnCl2, pH 7.5, 300mOsm).
2.3. Phenylmethylsulphonyl ﬂuoride (250mM)
43.5mg phenylmethylsulphonyl ﬂuoride was dissolved in 1ml
isopropanol and various concentrations were obtained by appro-
priate dilution with TBS-I.
2.4. Collection of samples
Human blood and serum samples were obtained from Volun-
tary Health Service, Taramani, Chennai and Lions Blood Bank,
Egmore, Chennai. Serum samples were diluted with an equal
volume of 0.9% physiological saline containing 0.02% sodium azideand stored at 25 1C, until use. Human serum of blood group AB
was used in all these assays, unless otherwise mentioned.
2.5. Vertebrate blood samples
Blood samples were obtained from various vertebrates listed
below:Sl.
no.Common
nameScientiﬁc name Source1. Human Homo sapiens Blood banks2. Rabbit Oryctolagus
cuniculus9>>>=
>>>;3. Rat Rattus
norvegicusOur laboratory4. Mouse Mus musculus
9
Chennai
5. Buffalo Bubalus bubalis >>>>=
>>>>;6. Ox Bos indicus
corporation
slaughter
house
Perambur,7. Sheep Ovis ariesChennai
Local chicken8. Goat Capra aegagrus
hircusstalls, Chennai9. Hen Gallus gallus
domesticusAll blood sample collections performed in the laboratory were
approved by Institutional Animal Ethical Committee (IAEC), India,
guidelines (360/01/a/CPCSEA). Samples were collected in Alsever’s
solution containing 100mg/ml streptomycin and stored at 10 1C.
2.6. Erythrocytes (RBC)
RBC were prepared by following the method of Maheswari
et al. [35], by centrifugation (400 g for 5min at 28 1C) and pellet
was ﬁnally suspended in respective buffers as 1.5% (v/v) RBC
suspension. Hen and sheep RBC prepared as mentioned above
were packed into 500ml pellets and used for cross adsorption test.
Note: Centrifugation was performed as mentioned above
throughout this study.
2.7. Fixation of RBC
Prepared RBC was ﬁxed by suspending the RBC pellet in PBS
(0.1M, pH 7.2) containing 5% formaldehyde for 24h at 10 1C. The
ﬁxed RBC were extensively washed in saline and resuspended in
TBS-III before use.
2.8. Hemagglutination assays
The hemagglutination (HA) assays were routinely performed
in V-bottom microtiter plates (Greiner, Nu¨rtingen, Germany) by
serial two-fold dilution of 25ml test samples (untreated or
treated-sera samples) against various vertebrate RBC types fol-
lowing the method of Maheswari et al. [35] and that of Garvey
et al. [36].
2.9. Induction of hemagglutinating activity in serum by various
proteases/detergents
500ml sera (blood group AB) were mixed with equal volumes of
each one of the freshly prepared ﬁve proteases including pronase,
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TBS-I) or one of the three detergent solutions, namely, SDS, Tween 20
and Triton X-100 (4 mg/ml in TBS-III), separately and incubated at
37 1C for 90min. In controls, serum samples were concurrently
incubated with equal volumes of TBS-I (for proteases) and TBS-III
(for detergents). All these test samples were centrifuged and the
supernatants were tested for HA activity against various vertebrate
RBC types. Detergents-treated sera samples were analysed for HA
using ﬁxed RBC types. Induction of pronase/SDS-induced hemagglu-
tinating activity was also analysed in sera of blood groups A, B, and O.
2.10. Determination of role of pronase
100ml serum was treated with an equal volume of heat-
inactivated pronase (1mg/ml; heated for 15min at 100 1C in a
water bath, centrifuged and supernatant used) and tested for HA
activity against hen RBC.
2.11. Pronase inhibition assay
100ml pronase (2mg/ml) was pre-incubated with an equal
volume of PMSF or EDTA at different concentrations (prepared in
TBS-I) for 60min at 28 1C. To this mixture, 200ml serum was
added and HA activity was tested against hen RBC.
2.12. Cross adsorption test
This assay was performed using 500ml each of trypsin- and
a-chymotrypsin-treated serum samples with equal volumes of
both sheep as well as hen RBC pellets separately, following the
method of Maheswari et al. [35] and the residual activity was
analysed against both the RBC types.
2.13. Time course analysis
500ml sera were treated with equal volumes of pronase,
trypsin or SDS, separately. 100ml was collected at various time
points, centrifuged and the supernatants were assayed for HA
activity. Pronase- or SDS-treated samples were tested using only
hen RBC, whereas, trypsin-treated samples were analysed against
both hen and sheep RBC.
2.14. Dosimetric analysis
100ml sera were mixed with an equal volume of different
concentrations of pronase or SDS solutions and incubated for
30min at 37 1C. Each reaction mixture was centrifuged and the
supernatant was assayed for HA activity against hen RBC.
2.15. Divalent cation dependency and EDTA sensitivity
The naturally occurring HA activity in serum was determined
against buffalo and rabbit RBC by two-fold serial dilution of 25ml
serum sample with different buffers, namely, TBS-I, TBS-II andTable 1
Hemagglutinating activity of untreated serum against various vertebrate RBC types.
Blood group identity
of serum
Serum hemagglutination titer against various RBC type
Human A Human B Human O Human AB
A 0 8 0 0
B 8 0 0 0
O 16 8 0 8
AB 0 0 0 0
a Data represent median titer values from six determinations for each RBC type usTBS-IV. The HA activity of trypsin-treated serum was analysed
against both hen and sheep RBC using these same buffers. The HA
activity of pronase-treated serum was analysed against hen RBC
extensively in TBS-II, III, IV, VI, VII and VIII. (RBC suspensions were
prepared in the respective buffers).
2.16. Hemagglutination-inhibition assays
Hemagglutination-inhibition assay was performed by follow-
ing the method of Maheswari et al. [35]. Several carbohydrates
(prepared in TBS-V), a phospholipid (prepared in TBS-I), aminoa-
cids and their derivatives (prepared in TBS-V) and glycoproteins
(prepared in TBS-III) were tested for their ability to inhibit the
natural, pronase- and trypsin-inducible HA activity in serum
against respective RBC types. pH of these test solutions were
adjusted to pH 7.5 using NaOH pellets.3. Results
3.1. Hemagglutination proﬁle of untreated serum
All serum samples (blood groups A, B, O and AB) agglutinated
buffalo and rabbit RBC with a titer of 16, rat and mouse RBC with
the titer of 8, whereas, they never agglutinated ox, sheep, goat
and hen RBC (Table 1).
3.2. Hemagglutination proﬁle of serum treated with proteases/
detergents
Among ﬁve proteases tested only pronase, trypsin and a-
chymotrypsin generated hemagglutinating activity in serum
(Table 2). Serum samples treated with pronase at a concentration
of 100 or 500mg/ml agglutinated hen RBC with a titer of 256,
whereas, the serum treated with trypsin or a-chymotrypsin at a
concentration of only 500mg/ml were found to agglutinate both
sheep and hen RBC with the titers of 64 and 128, respectively.
Among the three detergents, only SDS could generate HA
activity in the serum against all the four human RBC types as
well as ox, sheep and hen RBC, with the highest titer of 128 for the
avian RBC (Table 3).
Hemagglutination proﬁle of pronase and SDS-treated serum
(blood groups A, B and O) gave similar hemagglutination proﬁles
and agglutinated hen RBC with highest titer of 256 (Tables 4 and 5).
Similar HA proﬁles were observed with sera samples obtained
naturally and after recalciﬁcation of citrated whole blood or plasma
(data not shown). Furthermore, pre-treatment of hen RBC with
pronase or SDS; hen and sheep RBC with trypsin did not make them
susceptible to agglutination by untreated sera (data not shown).
Besides, pronase, SDS or trypsin by itself did not agglutinate hen or
sheep RBC (data not shown). Pronase/trypsin-treated samples were
stored at 10 1C, wherein, the HA activity generated in the sera treated
with pronase remained stable even after 3 weeks, interestingly, the
trypsin-treated sera samples after 24h retained the same high titer ofsa
Buffalo Rabbit Rat Mouse Ox Sheep Goat Hen
16 16 8 8 0 0 0 0
16 16 8 8 0 0 0 0
16 16 8 8 0 0 0 0
16 16 8 8 0 0 0 0
ing different stocks of pooled serum (single and multiple individuals).
Table 2
Hemagglutinating activity of serum (AB) treated with proteases against various vertebrate RBC types.
Serum
treatment
Concentration of
proteases (lg/ml)a
Hemagglutination titer against various RBC typesb
Human A Human B Human O Human AB Buffalo Rabbit Rat Mouse Ox Sheep Goat Hen
None 0 0 0 0 16 16 8 8 0 0 0 0
Pronase 100 0 0 0 0 4 8 8 8 0 0 0 256
500 0 0 0 0 4 8 8 8 0 0 0 256
Trypsin 100 0 0 0 0 8 8 8 4 0 0 0 0
500 0 0 0 0 8 8 8 4 0 64 0 128
a-Chymotrypsin 100 0 0 0 0 8 16 8 4 0 0 0 0
500 0 0 0 0 8 16 8 4 0 64 0 128
Papain 100 0 0 0 0 8 16 8 4 0 0 0 0
500 0 0 0 0 8 16 8 4 0 0 0 0
Pepsin 100 0 0 0 0 8 16 8 4 0 0 0 0
500 0 0 0 0 8 16 8 4 0 0 0 0
a Final concentration in the reaction mixture.
b Data represent median titer values from eight determinations for each RBC type using different stocks of pooled serum (single and multiple individuals).
Table 3
Hemagglutinating activity of serum (AB) treated with detergents against various vertebrate RBC types.
Serum treatment Hemagglutination titer against various RBC typesa
Human A Human B Human O Human AB Buffalo Rabbit Rat Mouse Ox Sheep Goat Hen
None 0 0 0 0 16 16 8 8 0 0 0 0
SDS 16 8 8 4 8 8 8 8 4 64 0 128
Triton X-100 0 0 0 0 8 8 8 8 0 0 0 0
Tween 20 0 0 0 0 8 8 8 8 0 0 0 0
a Data represent median titer values from three determinations for each RBC type using different stocks of pooled serum (single and multiple individuals).
Table 4
Hemagglutinating activity of serum treated with pronase against various vertebrate RBC types.
Serum samples tested Hemagglutination titer against various RBC typesa
Human A Human B Human O Human AB Buffalo Rabbit Rat Mouse Ox Sheep Goat Hen
Serum A
Untreated 0 8 0 0 16 16 8 4 0 0 0 0
Pronase-treated 0 8 0 0 2 16 64 2 0 0 0 128
Serum B
Untreated 8 0 0 0 64 32 8 4 0 0 0 0
Pronase-treated 16 0 0 0 2 32 64 8 0 0 0 256
Serum O
Untreated 8 8 0 4 16 32 16 4 0 0 0 0
Pronase-treated 16 16 0 8 64 64 16 4 0 0 0 256
Serum AB
Untreated 0 0 0 0 16 16 8 8 0 0 0 0
Pronase-treated 0 0 0 0 4 8 8 8 0 0 0 256
a Data represent median titer values from eight determinations for each RBC type using different stocks of pooled serum (single and multiple individuals).
Table 5
Hemagglutinating activity of serum treated with SDS against various vertebrate RBC types.
Serum samples
tested
Hemagglutination titer against various RBC typesa
Human A Human B Human O Human AB Buffalo Rabbit Rat Mouse Ox Sheep Goat Hen
Serum A
Untreated 0 8 0 0 16 16 8 4 0 0 0 0
SDS-treated 0 0 4 8 4 8 8 4 8 16 0 256
Serum B
Untreated 8 0 0 0 64 32 8 4 0 0 0 0
SDS-treated 0 0 2 16 4 8 8 4 8 16 0 256
Serum O
Untreated 8 8 0 4 16 32 16 4 0 0 0 0
SDS-treated 16 16 16 16 4 4 8 4 4 32 0 256
Serum AB
Untreated 0 0 0 0 16 8 8 8 0 0 0 0
SDS-treated 16 16 16 8 8 16 16 8 8 64 0 256
a Data represent median titer values from eight determinations for each RBC type using different stocks of pooled serum (single and multiple individuals).
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SDS-induced serum HA activity was stable for three weeks when
stored at 2872 1C (data not shown).3.3. Role of pronase and inhibition of pronase action
Serum treated with heat-inactivated pronase failed to generate
HA activity against hen RBC (Fig. 1), while that treated with active
pronase was able to generate HA. As depicted in Figs. 2 and 3,
dosimetric analysis of PMSF as well as EDTA revealed that at
12 and 50mM respectively, generation of HA activity was not
detectable in serum against hen RBC.3.4. Cross adsorption test
The results presented in Table 6 shows that in both trypsin/a-
chymotrypsin-treated serum samples, either of these two RBC
types completely adsorbed its own hemagglutinating activity as
well as the activity for the other RBC type after 3–4 sequential
adsorptions.0
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Fig. 1. Role of pronase in generation of hemagglutinating activity in serum against hen
stocks of pooled serum (single and multiple individuals). nNo hemagglutinating activit
Fig. 2. Dosimetric analysis of phenylmethylsulfonyl ﬂuoride (PMSF) on pronase inducib
values from three determinations using different stocks of pooled serum (single and m3.5. Time course analysis
Pronase, trypsin or SDS-treated sera were found to agglutinate
hen RBC within 15min and was same even up to 120min (Table 7).
HA of trypsin-treated serum against sheep RBC too gave an
identical proﬁle (data not shown).
3.6. Dosimetric analysis
The generation of HA activity was detectable in pronase
treated serum against hen RBC at 25mg/ml (titer¼8), reached
highest titer of 256 at 100mg/ml (Fig. 4), whereas, the HA activity
in SDS-treated serum was notable at 0.3mg/ml (titer¼4) and
reached the maximum titer at 2mg/ml (Fig. 5).
3.7. Divalent cation dependency and EDTA sensitivity
The untreated serum gave a HA titer of 16 against buffalo and
rabbit RBC in the presence of TBS-I or II. In the presence of TBS-IV
the serum gave the titers of 8 and 4 against these two RBC types,
respectively. Trypsin-treated serum gave a HA titer of 256 against*
Serum + Heat-inactivated Pronase
les tested
RBC. Data represent median titer values from three determinations using different
y was detectable.
le hemagglutinating activity in serum against hen RBC. Data represent median titer
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Fig. 3. Dosimetric analysis of EDTA on pronase inducible hemagglutinating activity in serum against hen RBC. Data represent median titer values from three
determinations using different stocks of pooled serum (single and multiple individuals). nNo hemagglutinating activity was detectable.
Table 6
Cross adsorption tests on trypsin or a-chymotrypsin-treated serum (AB).
Serum adsorbed witha HA titer against RBC types testedb
Hen RBC Sheep RBC
None 128 64
Hen RBC 0 0
Sheep RBC 0 0
a Three to four sequential 60min adsorption at 28 1C.
b Data represent median titer values from three determinations for each RBC
type using different stocks of pooled serum (single and multiple individuals).
Table 7
Time course analysis of hemagglutinating activity inducible in serum (AB) by
pronase, trypsin and SDS against hen RBC.
Time intervals
(min)
Hemagglutination titer against hen RBCa
Pronase-treated
serum
Trypsin-treated
serum
SDS-treated
serum
15 256 256 128
30 256 256 128
60 256 256 128
90 256 256 128
120 256 256 128
a Data represent median titer values from three determinations using different
stocks of pooled serum (single and multiple individuals).
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in the presence of TBS-I and not TBS-II and TBS-IV (Table 8). The
pronase-treated serum gave the HA titer of 256 against hen RBC
in TBS-II, -III, -IV, -VI, -VII and -VIII (Table 9).
3.8. Hemagglutination-inhibition assay
Off 53 carbohydrates tested, only eight carbohydrates were
found to inhibit HA activity of untreated serum against buffalo
RBC at the minimal inhibitory concentrations ranging from 12.5to 100mM (Table 10) and these include three glycosides, two
disaccharides, two trisaccharides and one tetrasaccharide.
Only three hexosamines inhibited the HA activity of pronase
treated serum against hen RBC at varying inhibitory concentra-
tions (Table 11).
Of the 19 diverse carbohydrates the HA of trypsin-treated
serum against only sheep RBC was inhibited by two N-acetylated
aminosugars, at the minimal inhibitory concentration of 25mM
(Table 12), while, three sialoglycoproteins, inhibited the HA
against both hen and sheep RBC with minimal inhibitory con-
centrations ranging from 0.312 to 2.50mg/ml (Table 13). In
contrast, asialo-BSM did not inhibit the activity, while, asialo-
fetuin did inhibit HA against sheep RBC at a concentration of
1.25mg/ml and was not inhibitory for agglutination of hen RBC
(Table 13).4. Discussion
Human plasma or serum is known to contain two distinct
types of naturally occurring humoral molecules capable of caus-
ing agglutination of RBC. The ﬁrst type includes conagglutinins
represented by natural antibodies (IgM), whose reactivity is
detectable with human RBC and the second type is the lectins
naturally occurring in human blood. In our study, untreated
serum agglutinated buffalo, rabbit, rat and mouse RBC, irrespec-
tive of their blood groups, but not ox, sheep, goat and hen RBC.
This agglutination observed may be due to previously reported six
lectins [14] or a new lectin, which yet requires further elucida-
tion. In all subsequent studies, human AB serum was used as it
did not possess conagglutinins.
Among ﬁve proteases tested, pronase, trypsin and a-chymo-
trypsin were effective elicitors of HA, while two other proteases
tested, papain and pepsin were ineffective. This discrepancy in
the efﬁciency of various proteases may be related to their distinct
substrate speciﬁcity, which also appeared to be reﬂected by
differential RBC binding property of molecules generated upon
action of these proteases on native serum components. Genera-
tion of HA was also observed in serum upon treatment with only
SDS, but not with Triton X-100 and Tween 20.
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Fig. 4. Dosimetric analysis of pronase inducible hemagglutinating activity in serum against hen RBC. Data represent median titer values from four determinations using
different stocks of pooled serum (single and multiple individuals). nNo hemagglutinating activity was detectable.
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Fig. 5. Dosimetric analysis of SDS inducible hemagglutinating activity in serum against hen RBC. Data represent median titer values from four determinations using
different stocks of pooled serum (single and multiple individuals). nNo hemagglutinating activity was detectable.
Table 8
Cation dependency and EDTA sensitivity of hemagglutinating activity in untreated
and trypsin-treated serum (AB) against various vertebrate RBC types.
Buffer
types testeda
Serum hemagglutination titerb
Buffalo RBCc Rabbit RBCc Hen RBCd Sheep RBCd
TBS-I 16 16 256 256
TBS-II 16 16 256 0
TBS-IV 8 4 256 0
a Each buffer was used for serial dilution of the sample as well as each RBC
suspension.
b Data represent median titer values from three determinations for each RBC
type using different stocks of pooled serum (single and multiple individuals).
c Target used for untreated sera.
d Target used for trypsin-treated sera.
Table 9
Cation dependency and EDTA sensitivity of pronase-induced hemagglutinating
activity in serum (AB) against hen RBC.
Buffer types
tested
Hemagglutination titer
against hen RBCa
TBS-II 256
TBS-III 256
TBS-IV 256
TBS-VI 256
TBS-VII 256
TBS-VIII 256
a Data represent median titer values from three determinations using different
stocks of pooled serum (single and multiple individuals).
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blood group identity or after recalciﬁcation of citrated whole blood
or plasma, shows that certain components targeted by pronase/SDS
are present in the systemic circulation and remain stable upon
exposure to anticoagulant as well as recalciﬁcation process. Thegeneration of HA is not due to direct action of these elicitors on RBC
targets, since they did not agglutinate them and also the serum
failed to agglutinate these targets treated with elicitors. Therefore, it
becomes apparent that the exogenous elicitors generated new type
of molecules by reacting only with certain serum components,
whose identity will be explored. All the HA activities observed in
untreated and treated sera were highly stable to storage with an
Table 10
Hemagglutination-inhibition of untreated AB serum (titer¼4) by various carbo-
hydrates against buffalo RBC.
Carbohydrates tested Maximum
concentration
tested (mM)
Minimum
inhibitory
concentration
(mM)a
Glycosides
p-nitrophenyl-a-D-glucopyranoside 50 12.5
p-nitrophenyl-b-D-galactopyranoside 100 25
Methyl-a-D-mannopyranoside 200 50
Disaccharides
Melibiose (gal a 1-6 glc) 200 25
Cellobiose (glc b 1-4 glc) 200 100
Trisaccharides
Rafﬁnose (gal a 1-6 glc a 1-2 fruc) 200 100
Melezitose (glc a 1-3 fruc b 2-1
glc)
200 25
Tetrasaccharide
Stachyose (gal a 1-6 gal a 1-6 glc b
1, 2 fruc)
200 50
The following carbohydrates did not inhibit the hemagglutinating activity and
unless otherwise stated, all carbohydrates were tested at a concentration up to
200mM: N-acetylgalactosamine, N-acetylglucosamine, N-acetylmannosamine,
N-acetylneuraminic acid (20mM), b-allose, D-arabinose, L-arabinose, colominic
acid (10mg/ml), 2-deoxy-D-glucose, 2-deoxy-D-galactose, dextran-T70 (10mg/ml),
dextran-T500 (10mg/ml), diacetylchitobiose (50mM), D-fructose, D-fucose
(100mM), L-fucose (100mM), galactosamine, galactose, galacturonic acid,
b-gentiobiose, glucosamine, glucose, glucuronic acid, inulin (5mg/ml), lactose,
laminarin (10mg/ml), mannan (10mg/ml), mannosamine, mannose, maltose,
maltotriose, methyl-a-D-galactopyranoside, methyl-b-D-galactopyranoside,
methyl-b-D-glucopyranoside, p-nitrophenyl-a-galactopyranose (50mM), p-nitro-
phenyl-b-D-glucopyranoside (100mM), palatinose, rafﬁnose, L-rhamnose, L-sor-
bose, sucrose, trehalose, turanose and xylose.
a The assay was repeated four times for each carbohydrate with identical
results using different stocks of pooled serum (single and multiple individuals).
Table 11
Hemagglutination-inhibition of pronase-treated AB serum (titer¼4) by various
carbohydrates, amino acids and a phospholipid against hen RBC.
Carbohydrates tested Maximum concentration
tested (mM)
Minimum
inhibitory
concentration (mM)a
Hexoses
Glucose 200 –
Galactose 200 –
Mannose 200 –
Hexosamines
Glucosamine 200 50
Galactosamine 200 100
Mannosamine 200 25
N-acetyl hexosamines
N-acetylglucosamine 200 –
N-acetylgalactosamine 200 –
N-acetylmannosamine 200 –
The following carbohydrates did not inhibit the HA activity and unless
otherwise stated, all carbohydrates were tested at concentration up to 200mM:
N-acetylneuraminic acid (100mM), b-D-allose, D-arabinose, L-arabinose,
cellobiose, colominic acid (10mg/ml), 2-deoxy-D-galactose, 2-deoxy-D-glucose,
dextran T70 (10mg/ml), dextran T500 (10mg/ml), D-fructose, D-fucose (100mM),
L-fucose (100mM), D-galacturonic acid, gentiobiose, D-glucuronic acid, inulin
(5mg/ml), lactose, laminarin (10mg/ml), maltose, maltotriose, mannan (10mg/ml),
mannose, melezitose, melibiose, methyl-a-D-galactopyranoside, methyl-b-D-
galactopyranoside, methyl-a-D-glucopyranoside, methyl-b-D-glucopyranoside,
methyl-a-D-mannopyranoside, p-nitrophenyl-a-D-galactopyranoside (50mM),
p-nitrophenyl-b-D-galactopyranoside (100mM), p-nitrophenyl-a-D-glucopyrano-
side (50mM), p-nitrophenyl-b-D-glucopyranoside (100mM), palatinose, rafﬁnose,
L-rhamnose, ribose, L-sorbose, stachyose, sucrose, turanose, trehalose and
D-xylose.The following amino acids also did not inhibit the HA activity at
concentration tested up to 200mM: N-acetylglutamine, N-acetylglycine, N-acet-
ylhydroxyproline, O-acetylhydroxyproline, L-Alanine, L-Arginine monochloride,
L-Cystine, L-Cysteine.HCl, L-Glutamic acid, Glutamine, Glycine, L-Histidine,
L-Hydroxyproline, Isoleucine, L-Lysine.HCl, L-Methionine, DL-Nor-Leucine,
Ornithine.HCl, Phenylalanine, L-Proline, DL-Serine, DL-Threonine, DL-Tryptophan,
L-Tyrosine and DL-Valine Phosphoryl choline (a phospholipid) tested up to a
concentration of 200mM was non-inhibitory.
- Non-inhibitory.
a The assay was repeated four times for each test substance with identical
results using different stocks of pooled serum (single and multiple individuals).
Table 12
Hemagglutination-inhibition of trypsin-treated AB serum (titer¼4) by various
carbohydrates and a phospholipid against hen and sheep RBC.
Carbohydrates
tested
Maximum
concentration
tested (mM)
Minimum inhibitory
concentration (mM)a
Hen RBC Sheep RBC
Hexoses
Glucose 200 – –
Galactose 200 – –
Mannose 200 – –
Hexosamines
Glucosamine 200 – –
Galactosamine 200 – –
Mannosamine 200 – –
N-acetyl hexosamines
N-acetylglucosamine 200 – –
N-acetylgalactosamine 200 – –
N-acetylmannosamine 200 – 25
Sialic acid
N-acetylneuraminic acid 100 – 25
The following carbohydrates did not inhibit the hemagglutinating activity against
both hen and sheep RBC and unless otherwise stated, all test substances were
tested at a concentration up to 200mM: arabinose, colominic acid (10mg/ml),
dextran T70 (10mg/ml), D-fructose, laminarin (10mg/ml), mannan (10mg/ml),
ribose, sucrose and xylose. Phosphoryl choline (a phospholipid) tested up to a
concentration of 200mM was non-inhibitory.
- Non-inhibitory.
a The assay was repeated three times for each test substance with identical
results using different stocks of pooled serum (single and multiple individuals).
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sheep RBC. This observation indicated the presence of two types of
activities in trypsin-treated serum: stable HA against hen RBC and
an unstable HA against sheep RBC.
The inability of heat-inactivated pronase to generate HA in sera
show that pronase was solely responsible for the detected activity.
Inhibition of HA in pronase-treated serum by PMSF and EDTA
(protease inhibitors), clearly suggests that this protease generates
HA by proteolytic cleavage of certain serum components. The most
potent inhibitor was PMSF because, the HA activity was completely
inhibitable at a lower concentration than EDTA.
The ability of SDS to generate such agglutinin molecules may
be attributed to conformational changes inﬂicted in various
serum biomolecules [37]. Nevertheless, it is notable that in
contrast to protease-treated serum the molecules induced upon
SDS treatment could cross react with various human RBC types,
suggesting differential characteristics.
Cross adsorption tests were performed to assess RBC binding
speciﬁcity of newly generated agglutinin molecules where, these
two RBC types equivocally adsorbed the agglutinating activity
from the sera treated with trypsin or a-chymotrypsin, thereby
suggesting that these agglutinin molecules are capable of reacting
with both hen and sheep RBC.
Time course analysis revealed that pronase, trypsin or SDS
could rapidly generate HA. Dosimetric response in HA generation
was observed with both pronase and SDS, wherein, pronase was
most efﬁcient to generate HA at a low concentration of 100mg/ml,
because it is a mixture of several proteases and non-speciﬁc in
action [38].
Table 13
Hemagglutination-inhibition of trypsin-treated AB serum (titer¼4) by glycopro-
teins against hen and sheep RBC.
Glycoproteins
tested
Maximum
concentration
tested (mg/ml)
Minimum inhibitory
concentration (mg/ml)a
Hen RBC Sheep RBC
Bovine submaxillary mucin (BSM) 10 1.25 0.312
Asialo-BSM 5 – –
Fetuin 10 2.50 2.50
Asialo-fetuin 5 – 1.25
Porcine thyroglobulin 10 5 0.625
– Non-inhibitory.
a The assay was repeated three times for each glycoprotein with identical
results using different stocks of pooled serum (single and multiple individuals).
B. Manikandan, M. Ramar / Results in Immunology 2 (2012) 132–141140Most of the naturally occurring serum lectins were cation
dependent and sensitive to EDTA, but in our study all the
observed HA were cation independent and insensitive to EDTA
suggesting that new type of molecules has been detected and it
warrants more investigation in detail. However, trypsin-treated
serum showed once again a variation, wherein, the HA against
sheep RBC was cation dependent and EDTA sensitive. This result
further conﬁrms the presence of two types of HA molecules in
trypsin-treated serum.
HA of untreated serum was inhibitable by wide range of carbohy-
drates such as glycoside derivatives with p-nitrophenyl or methyl
group, di- or oligo-saccharides containing terminal glucose or galac-
tose with varying glycosidic linkages and this proﬁle was not over-
lapping with any of the speciﬁcities reported for the naturally
occurring serum lectins. Furthermore, it was not comparable too as
to whether the HA observed was due to reported lectins or some new
molecules since some carbohydrates were not tested in previous
reports. Thus, it is likely that the lectins reported previously in serum
or some new type of molecules yet to be explored may be responsible
for the HA. Interestingly, HA of pronase-treated serum was inhibited
only by the three hexosamines indicating generation of anew type of
lectin molecules, termed neo-lectin with distinct speciﬁcity varying
from that of natural lectins reported by other investigators and us. In
trypsin-treated serum, different inhibitors could inhibit HA against
hen and sheep RBC implicating generation of two kinds of neo-lectin
molecules that differ in ligand binding speciﬁcities.5. Conclusion
Overall, to conclude, the ﬁndings of this study clearly demon-
strate, for the very ﬁrst time, a complete HA proﬁle for untreated
serum against various vertebrate RBC types and the possibility for
generation of lectin molecules in human serum by exogenous
elicitors. Besides, these neo-lectin molecules generated by pro-
teases implicated restriction in their self-reactivity (with human
RBC types) and thus it is envisaged that they might potentiate
immuno-defense process in vivo against foreign invaders.Acknowledgement
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